Somnomed Ltd - Asset Resilience Ratio

Latest as of December 2024: 24.67%

Somnomed Ltd (SOM) has an Asset Resilience Ratio of 24.67% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Somnomed Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets

AU$18.50 Million
≈ $13.09 Million USD Cash + Short-term Investments

Total Assets

AU$74.99 Million
≈ $53.06 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Somnomed Ltd's Asset Resilience Ratio has changed over time. See SOM net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Somnomed Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Somnomed Ltd.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$18.50 Million 24.67%
Short-term Investments AU$0.00 0%
Total Liquid Assets AU$18.50 Million 24.67%

Asset Resilience Insights

  • Good Liquidity Position: Somnomed Ltd maintains a healthy 24.67% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Somnomed Ltd Industry Peers by Asset Resilience Ratio

Compare Somnomed Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Inspire Medical Systems Inc
NYSE:INSP
Medical Devices 20.29%
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186
Medical Devices 0.84%
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
Medical Devices 19.31%
Stratec SE
XETRA:SBS
Medical Devices 0.30%
Duearity AB
ST:DEAR
Medical Devices 145.62%
Anteris Technologies Global Corp
AU:AVR
Medical Devices 33.27%
Polynovo Ltd
AU:PNV
Medical Devices 0.04%

Annual Asset Resilience Ratio for Somnomed Ltd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Somnomed Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-06-30 23.18% AU$16.18 Million
≈ $11.45 Million
AU$69.80 Million
≈ $49.39 Million
+4.04pp
2023-06-30 19.13% AU$11.96 Million
≈ $8.46 Million
AU$62.49 Million
≈ $44.22 Million
-7.80pp
2022-06-30 26.93% AU$15.64 Million
≈ $11.07 Million
AU$58.09 Million
≈ $41.10 Million
-10.65pp
2021-06-30 37.58% AU$21.11 Million
≈ $14.94 Million
AU$56.17 Million
≈ $39.74 Million
-11.33pp
2020-06-30 48.91% AU$30.17 Million
≈ $21.35 Million
AU$61.69 Million
≈ $43.65 Million
+26.76pp
2019-06-30 22.15% AU$7.70 Million
≈ $5.45 Million
AU$34.75 Million
≈ $24.59 Million
-7.14pp
2018-06-30 29.29% AU$13.38 Million
≈ $9.47 Million
AU$45.70 Million
≈ $32.33 Million
-5.19pp
2017-06-30 34.48% AU$14.21 Million
≈ $10.05 Million
AU$41.21 Million
≈ $29.16 Million
--
2016-06-30 0.00% AU$0.00
≈ $0.00
AU$40.43 Million
≈ $28.60 Million
--
pp = percentage points

About Somnomed Ltd

AU:SOM Australia Medical Devices
Market Cap
$86.03 Million
AU$121.59 Million AUD
Market Cap Rank
#19836 Global
#652 in Australia
Share Price
AU$0.56
Change (1 day)
+0.91%
52-Week Range
AU$0.53 - AU$0.89
All Time High
AU$3.28
About

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product desig… Read more